TTRX compared with RYM: revenue, margins and what each company keeps, and the suppliers and customers both name

TTRXTurn Therapeutics Inc.

Mkt capRevenueRevenue

RYMRythm, Inc.

Mkt capRevenueRevenue

Compare

TTRXTurn Therapeutics Inc.

RYMRythm, Inc.

Price

Mkt cap

Revenue

Revenue flow Supply chain Price Co-movers Event sensitivity Earnings history

Save comparison

Earnings history

News Findings Companies A–Z Pricing Methodology Sources Corrections About Terms

Not investment advice. Not a broker-dealer. Indices shown as ETF proxies. Supply-chain data CC BY 4.0; market data not redistributable.

Listed on One’s Vibe · live-checked · Oct ’26

Desk News Calendar Saved

Earnings history

last 4 reports each · paired by recencyMethod ›

TTRX1 of 4 reports

Reportimpliedrealized× implied

Q2 FY26—▼−6.45%—

RYM2 of 4 reports

Reportimpliedrealized× implied

Q3 FY26—▲+6.73%—

Q2 FY26—▲+23.20%—

= impliedTTRX realized, solidRYM realized, hatchedOne scale, both sides: full bar = 24%× = |realized| ÷ impliedSource: market data

TTRXTurn Therapeutics Inc.

9.13▲+2.15%· post 9.14

Mkt cap$282.4MRevenue—Revenue—

RYMRythm, Inc.

16.42▲+1.05%· post 16.42

ClosedNov 6 '26

Mkt cap$122.3MRevenue$24MQ3 FY26Revenue$17MFY25

Compare

ClosedNov 6 '26

TTRXTurn Therapeutics Inc.

RYMRythm, Inc.

9.13▲+2.15%post 9.14

Price

16.42▲+1.05%post 16.42

$282.4M

Mkt cap

$122.3M

—

Revenue

$24MQ3 FY26

—

Revenue

$17MFY25

TTRX9.13▲+2.15%vsRYM16.42▲+1.05%ClosedNov 6 '26